Screener
PTC Therapeutics PTCT Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable and accrued expenses | $313,050 | $381,272 |
| Current portion of long-term debt | 286,937 | 286,631 |
| Deferred revenue | 498 | 2,040 |
| Operating lease liabilities- current | 12,078 | 12,484 |
| Finance lease liabilities- current | 6,000 | 3,000 |
| Liability for sale of future royalties- current | 305,041 | 283,000 |
| Total current liabilities | 923,604 | 968,427 |
| Operating lease liabilities- noncurrent | 90,072 | 93,583 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's operating lease liabilities (current)?
- PTC Therapeutics (PTCT) reported operating lease liabilities (current) of $12.08M in Q1 2026.
- How has PTC Therapeutics's operating lease liabilities (current) changed year-over-year?
- PTC Therapeutics's operating lease liabilities (current) increased by 5.4% year-over-year, from $11.46M to $12.08M.
- What is the long-term trend for PTC Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), PTC Therapeutics's operating lease liabilities (current) has grown at a 10.8% compound annual growth rate (CAGR), from $7.47M to $12.48M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about PTC Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude